Bird Flu (ترجمة ا/اشرف جورج )

تهنىء اسرة المنتدى والمدرسة والعلاقات العامة الاستاذة /زكيه الباز على خطبة ابنتها الدكتور مى محمد عبد العليم على الدكتور محمد حامد مصباح..........

Bird Flu / Avian Flu News From Medical News Today
Previous Flu Viruses Provided Some Immunity To Current Swine Flu, Study Shows
University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years. These molecular sites appear to result in some level of immunity to the new virus in people who were exposed to the earlier influenza viruses.
ImmuneRegen BioSciences(R) Initiates Homspera(R) Studies Against Global Influenza Threat
ImmuneRegen BioSciences, Inc.

, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist.
Protecting Humans And Animals From Diseases In Wildlife
Avian influenza (H5N1), rabies, plague, Bovine Spongiform Encephalopathy (BSE), and more recently swine flu (H1N1) are all examples of diseases that have made the leap from animals to humans. As the list continues to grow, experts at The University of Nottingham are to lead a project aimed at developing a state-of-the-art pan-European surveillance system to monitor emerging and re-emerging infections in wildlife.
News From Annals Of Internal Medicine, October 6, 2009
Early Releases: 1. Earlier H1N1 Vaccination Prevents More Deaths, Saves Health Care Costs A vaccine for H1N1 influenza is anticipated to become available this fall. With the amount and timing of vaccine release still in question, policy makers struggle to set priorities regarding who should be vaccinated when.
Medicago Begins Human Clinical Testing With Its Avian Flu Pandemic Vaccine
Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has initiated a Phase I human clinical trial with its H5N1 Avian Influenza vaccine ("H5N1 vaccine"). Enrolment is ongoing and vaccination has commenced.
H1N1 Flu In Turkeys May Spread
The detection of an H1N1 virus in turkeys in Chile raises concern that poultry farms elsewhere in the world could also become infected with the pandemic flu virus currently circulating in humans, FAO said today. Chilean authorities reported on 20 August that the pandemic H1N1/2009 virus was present in turkeys in two farms near the seaport of Valparaiso, Chile.
Lakewood-Amedex Inc. To Develop Broad Spectrum Influenza Drug To Include H1N1 And H5N1 Type A Strains
Lakewood-Amedex Inc., (L-A), the anti-infectives biopharmaceutical company developing a unique portfolio of anti-bacterial and anti-viral products including NuBiotics, a novel family of synthetic anti-bacterial compounds, and anti-viral products against hepatitis, HIV and influenza, announced today that it is accelerating development of its broad spectrum anti-influenza product into clinical studies.
Adapting To A New Host: Bird Flu Leaves The Nest
Current research suggests that viral polymerase may provide a new therapeutic target for host-adapted avian influenza. The related report by Gabriel et al, "Spread of Infection and Lymphocyte Depletion in Mice Depends on Polymerase of Influenza Virus" appears in the September 2009 issue of the American Journal of Pathology. Highly pathogenic avian influenza, commonly known as bird flu, is a strain of the influenza virus that has adapted to infect birds.
NexBio(R) Demonstrates DAS181 (Fludase(R)), A Broad-Spectrum Drug Candidate, Inhibits Influenza Viral Infection In Human Lung Tissue
NexBio, Inc. announced the publication "DAS181 Inhibits H5N1 Influenza Lung Virus Infection of Human Lung Tissues" in the September, 2009 issue of the journal Antimicrobial Agents and Chemotherapy (AAC). DAS181 (Fludase((R))) is an investigational drug candidate in clinical development for Influenza-Like Illness. Unlike neuraminidase inhibitors (e.g.
Medicago Receives Regulatory Approval To Begin Human Clinical Testing With Its Avian Flu Pandemic Vaccine
Medicago Inc. (TSX VENTURE:MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announced that it has received clearance from Health Canada to commence a Phase I human clinical trial with its H5N1 Avian Influenza vaccine ("H5N1 vaccine"). Enrollment of

volunteers is now underway.

جزاك الله خيرا

» شرح لـــ qution tag اعداد ا/اشرف جورج
» كن مثاليا(أ/عاطف جورج)
» ما اجمل (أ/عاطف جورج)
» شرح باور بوينت للدوال الحقيقية (أ/ عاطف جورج )